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Background
We have previously reported dramatic increases in
immune responses induced by DNA vaccines delivered by
electroporation (EP), resulting in improved control of
viral replication following a SIVmac251 challenge. We
compared the immunogenicity of DNA+EP to the Ad5
vaccine, the most potent recombinant viral vector for the
generation of CTL responses in macaques and humans.
Futhermore, we were interested in examining the effect of
prime/boost strategies using these two platforms on the
magnitude and phenotype of the immune response.
Methods
Three groups of rhesus macaques (n = 5) were immunized
with consensus SIVmac gag, env, pol constructs with plas-
mid IL-12 by EP (DNA+EP), Ad5SIVgag, pol, nef (Ad5) or
saline alone (Naive). The DNA+EP group received 4
immunizations and the Ad5 group received 3 immuniza-
tions. Five months following the last immunization the
DNA+EP group was boosted twice with the Ad5 vaccine
and vice versa. Cellular responses were assessed by IFNγ
ELISpot, CFSE proliferation, and ICS for polyfunctional
populations.
Results
The Ad5 group had an early three-fold enhancement of
IFNγ responses compared to the DNA+EP group (1925 ±
610 and 666 ± 297 SFU/106 PBMCs, respectively). Subse-
quent Ad5 immunizations failed to boost responses while
the DNA+EP group reached a robust 9776 ± 1589 SFU/
106 PBMCs. Proliferation was five-fold better and the
magnitude of the polyfunctional CD8+ T cell response
was a log higher in the DNA+EP group compared to the
Ad5 group (1.31% and 0.11%, respectively). When
boosted with DNA, the Ad5 polyfunctional response
increased six-fold (0.67%) and the DNA+EP group had a
7-fold increase (8.28%) following an Ad5 booster immu-
nization.
Conclusion
Following the initial series of immunizations the
DNA+EP group surpassed the Ad5 group in terms of mag-
nitude, proliferation, and polyfunctionality. However
both groups demonstrated a boost in all responses follow-
ing crossover immunizations. These results have signifi-
cant implications for HIV vaccine development and
warrant further study.
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